Products & Services
Applications

Applications

Nanopore sequencing offers advantages in all areas of research. Our offering includes DNA sequencing, as well as RNA and gene expression analysis and future technology for analysing proteins.

Learn about applications
View all Applications
Resources
News Explore
Contact Get started
Resource Centre

Chia-Lin Wei

Nanopore sequencing reveals high-resolution structural variation in the cancer genome

About Chia-Lin Wei

Dr. Wei joined the Jackson Laboratory in 2016 as the Director of Genomic Technologies, where she actively engages the development and application of innovative sequencing based genomic technologies to explore genome function and make genome-based medical discoveries for solutions in treating human disease. Dr. Wei got her Ph.D. (Microbiology) from University of California at Davis. Prior to that she was at the Joint Genome Institute (JGI), joining in 2010. She was responsible for Department of Energy (DOE) user facility genomic sequencing operation as well as sequencing related technology development effort within the Genomic Technology Department. Dr. Wei moved to JGI after an eight-year stint at Genome Institute of Singapore (GIS) and was responsible for establishing a sequencing technology platform and genome biology program. Dr. Wei group’s research activity involves the development of innovative sequencing-based genomic technologies to explore functional genomic elements for transcriptional and epigenetic regulation. She applies these approaches to interrogate genomic, characterize transcriptomes and chromatin structures.

Abstract

Dr. Wei joined the Jackson Laboratory in 2016 as the Director of Genomic Technologies, where she actively engages the development and application of innovative sequencing based genomic technologies to explore genome function and make genome-based medical discoveries for solutions in treating human disease. Dr. Wei got her Ph.D. (Microbiology) from University of California at Davis. Prior to that she was at the Joint Genome Institute (JGI), joining in 2010. She was responsible for Department of Energy (DOE) user facility genomic sequencing operation as well as sequencing related technology development effort within the Genomic Technology Department. Dr. Wei moved to JGI after an eight-year stint at Genome Institute of Singapore (GIS) and was responsible for establishing a sequencing technology platform and genome biology program. Dr. Wei group’s research activity involves the development of innovative sequencing-based genomic technologies to explore functional genomic elements for transcriptional and epigenetic regulation. She applies these approaches to interrogate genomic, characterize transcriptomes and chromatin structures.

Back
Open a chat to talk to our sales team
FAQs

FAQs

Search